inhibition of human glutathione reductase by s nitrosoglutathione Therapeutic potential S-nitrosoglutathione inhibitor in B cell-driven experimental autoimmune encephalomyelitis Frontiers | ROS-Mediated Inhibition of

10.3390/ijms26062503 110 SharpR

Nine percent of all B 12 tests had an abnormal result

The levels of several enzymes controlling de novo serine synthesis such as phosphoserine phosphatase (PSPH), phosphoglycerate dehydrogenase (PHGDH), phosphoserine aminotransferase 1 (PSAT1) and have been identified differentially elevated in breast cancer cells with high propensity for bone metastasis as compared with those without metastatic potency [87], implicating the stimulatory role of serine on osteoclast formation and osteoclastogenesis [87, 88]

Navitoclax (ABT-263), another inhibitor of the BCL-2 family members, has also been used in many different studies over the years for its ability to eliminate senescent cells by inducing apoptosis

10.3969/j.issn.1002-266X.2013.10.030 177 ShenL.YingZ.YuL.LiuX.JinQ